<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01606319</url>
  </required_header>
  <id_info>
    <org_study_id>AsthmaNet 005</org_study_id>
    <secondary_id>1U10HL098115</secondary_id>
    <nct_id>NCT01606319</nct_id>
  </id_info>
  <brief_title>Acetaminophen Versus Ibuprofen in Children With Asthma</brief_title>
  <acronym>AVICA</acronym>
  <official_title>Acetaminophen vs. Ibuprofen in Children With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Acetaminophen Versus Ibuprofen in Children with Asthma study will test the primary
      hypothesis that in preschool children 12-59 months of age with persistent asthma on
      standardized asthma therapy, the number of asthma exacerbations requiring systemic
      corticosteroids will be more frequent in children randomized to receive acetaminophen as
      compared to those randomized to receive ibuprofen on an as needed basis for fevers and pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AVICA is a 48-week randomized therapeutic trial involving two parallel treatment arms:
      acetaminophen and ibuprofen. Participating children will be randomized to receive either
      acetaminophen or ibuprofen administered as needed per parental decision for fever and
      analgesia. This study will address which is the most appropriate antipyretic-analgesic
      medication in young children with asthma, and will inform both clinicians and parents seeking
      to treat children with fever and pain. Given the high frequency of administration of these
      drugs, this study will have a significant impact on pediatric healthcare regardless of
      whether a differential effect is discovered as significant uncertainty currently exists as to
      whether acetaminophen use is associated with increased asthma symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exacerbation Frequency</measure>
    <time_frame>last 46 weeks of 48 week treatment period</time_frame>
    <description>the number of asthma exacerbations requiring systemic corticosteroids</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Days</measure>
    <time_frame>last 46 weeks of 48 week treatment period</time_frame>
    <description>proportion of study days on which asthma was controlled, measured by electronic diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Rescue Medication Use</measure>
    <time_frame>last 46 weeks of 48 week treatment period</time_frame>
    <description>average albuterol rescue use per week, measured by electronic diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Utilization</measure>
    <time_frame>last 46 weeks of 48 week treatment period</time_frame>
    <description>frequency of unscheduled physician visits, emergency department visits or hospitalizations for asthma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Asthma</condition>
  <condition>Wheezing</condition>
  <arm_group>
    <arm_group_label>acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acetaminophen given as needed for pain or fever</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ibuprofen given as needed for pain or fever</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>15 mg/kg every 6 hours as needed</description>
    <arm_group_label>acetaminophen</arm_group_label>
    <other_name>tylenol</other_name>
    <other_name>paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>9.4 mg/kg every 6 hours as needed</description>
    <arm_group_label>ibuprofen</arm_group_label>
    <other_name>motrin</other_name>
    <other_name>advil</other_name>
    <other_name>nonsteroidal anti-inflammatory drug</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  12-59 months of age.

          -  If the child is not currently taking long-term asthma controller therapy (meaning that
             the child has taken no inhaled corticosteroid or leukotriene receptor antagonist
             medication whatsoever over the past 6 months), then one of the following criteria must
             be met:

               -  Daytime asthma symptoms more than two days per week (average over the past 4
                  weeks),

               -  At least one nighttime awakening from asthma (over the past 4 weeks),

               -  Two or more asthma exacerbations requiring systemic corticosteroids in the
                  previous 6 months,

               -  Four or more wheezing episodes in the previous 12 months.

          -  If the child is currently taking long-term asthma controller therapy (meaning that the
             child has taken daily or intermittent/as-needed inhaled corticosteroid or leukotriene
             receptor antagonist over the past 6 months), then one of the following criteria must
             be met:

               -  Taking inhaled corticosteroid or leukotriene receptor antagonist for more than 3
                  months (or more than 90 days) out of the previous 6 months (or 180 days),

               -  Daytime asthma symptoms more than two days per week (average over the past 4
                  weeks),

               -  More than one nighttime awakening from asthma (over the past 4 weeks),

               -  Two or more asthma exacerbations requiring systemic corticosteroids in the
                  previous 12 months,

               -  Four or more wheezing episodes in the previous 12 months.

          -  Up to date with immunizations, including varicella (unless the subject has already had
             clinical varicella).

          -  Willingness to provide informed consent by the child's parent or guardian.

        Exclusion Criteria:

          -  Allergic reaction to the study medications or any component of the study drugs,
             including (but not limited to) urticaria, rash, angioedema, or hypotension following
             delivery,

          -  Chronic medical disorders that could interfere with drug metabolism/excretion (for
             instance chronic hepatic, biliary, or renal disease),

          -  Chronic medical disorders that may increase the risk of drug-related injury, including
             (but not limited to):

               -  Osteogenesis imperfecta (increased risk of bone demineralization/fracture with
                  corticosteroid therapy),

               -  Crohn's disease, ulcerative colitis, juvenile rheumatoid arthritis, clotting
                  disorders, or Factor deficiency (increased risk of bleeding with corticosteroid
                  therapy),

               -  G6PD deficiency (increased risk of hemolytic anemia with acetaminophen use),

               -  Phenylketonuria (potential for aspartame exposure with study interventions),

               -  Seizure disorder treated with anticonvulsants (risk of acetaminophen toxicity
                  with carbamazepine), or

               -  History of clotting disorders or Factor deficiency (increased risk of bleeding
                  with corticosteroids),

          -  Co-morbid disorders associated with wheezing including (but not limited to) immune
             deficiency disorders, cystic fibrosis, aspiration, clinically-relevant
             gastroesophageal reflux, tracheomalacia, congenital airway anomalies (clefts,
             fistulas, slings, rings), bronchiectasis, bronchopulmonary dysplasia, and/or history
             of premature birth before 35 weeks gestation,

          -  Significant developmental delay/failure to thrive, defined as 5th percentile for
             height and/or weight or crossing of two major percentile lines during the last year
             for age and sex,

          -  History of a near-fatal asthma exacerbation requiring intubation or assisted
             ventilation,

          -  No primary medical caregiver (e.g., a nurse practitioner, physician assistant,
             physician, or group medical practice such as a hospital-based clinic) whom the subject
             can contact for primary medical care,

          -  Three or more hospitalizations in the previous 12 months for wheezing or respiratory
             illnesses,

          -  Treatment with 5 or more courses of systemic corticosteroids (oral, intramuscular or
             intravenous) in the past 6 months,

          -  Current use of higher than step 2 NAEPP asthma guideline therapy

          -  If receiving allergy shots, change in the dose within the past 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>59 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William B Busse, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona College of Medicine</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital &amp; Research Center Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center/Stroger Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainbow Babies and Children's Hospital, Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2012</study_first_posted>
  <results_first_submitted>September 13, 2016</results_first_submitted>
  <results_first_submitted_qc>November 17, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 16, 2017</results_first_posted>
  <last_update_submitted>November 17, 2016</last_update_submitted>
  <last_update_submitted_qc>November 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>dave mauger</investigator_full_name>
    <investigator_title>Principal Investigator, AsthmaNet Data Coordinating Center</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Wheezing</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>exacerbations</keyword>
  <keyword>pain</keyword>
  <keyword>fever</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Respiratory Sounds</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen</title>
          <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
        </group>
        <group group_id="P2">
          <title>Ibuprofen</title>
          <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="150"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="116"/>
                <participants group_id="P2" count="110"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen</title>
          <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
        </group>
        <group group_id="B2">
          <title>Ibuprofen</title>
          <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="150"/>
            <count group_id="B2" value="150"/>
            <count group_id="B3" value="300"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.3" spread="12.9"/>
                    <measurement group_id="B2" value="39.4" spread="13.6"/>
                    <measurement group_id="B3" value="39.9" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                    <measurement group_id="B2" value="113"/>
                    <measurement group_id="B3" value="228"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="148"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of urgent care and ED visits in the past year</title>
          <units>urgent care/ED visits per year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.1" spread="2.5"/>
                    <measurement group_id="B2" value="3.0" spread="2.3"/>
                    <measurement group_id="B3" value="3.1" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Oral Corticosteroid (OCS) courses in the past 6 months</title>
          <units>OCS courses per 6 months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" spread="1.1"/>
                    <measurement group_id="B2" value="1.2" spread="1.0"/>
                    <measurement group_id="B3" value="1.1" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>IgE (kU/L)</title>
          <units>kU/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" lower_limit="19" upper_limit="176"/>
                    <measurement group_id="B2" value="70" lower_limit="24" upper_limit="252"/>
                    <measurement group_id="B3" value="70" lower_limit="22" upper_limit="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Allergen Test</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Positive test</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative test</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Exacerbation Frequency</title>
        <description>the number of asthma exacerbations requiring systemic corticosteroids</description>
        <time_frame>last 46 weeks of 48 week treatment period</time_frame>
        <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
          </group>
        </group_list>
        <measure>
          <title>Exacerbation Frequency</title>
          <description>the number of asthma exacerbations requiring systemic corticosteroids</description>
          <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
          <units>asthma exacerbations per 46 weeks</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" lower_limit=".65" upper_limit="1.02"/>
                    <measurement group_id="O2" value=".87" lower_limit=".69" upper_limit="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.67</p_value>
            <method>log-linear model</method>
            <method_desc>log-linear model in which the number of exacerbations was assumed to follow a negative binomial distribution</method_desc>
            <param_type>relative rate</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.69</ci_lower_limit>
            <ci_upper_limit>1.28</ci_upper_limit>
            <estimate_desc>relative rate with acetaminophen in the numerator and ibuprofen in the denominator</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Control Days</title>
        <description>proportion of study days on which asthma was controlled, measured by electronic diary</description>
        <time_frame>last 46 weeks of 48 week treatment period</time_frame>
        <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Control Days</title>
          <description>proportion of study days on which asthma was controlled, measured by electronic diary</description>
          <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
          <units>proportion of days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".86" lower_limit=".84" upper_limit=".88"/>
                    <measurement group_id="O2" value=".87" lower_limit=".85" upper_limit=".89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.039</ci_lower_limit>
            <ci_upper_limit>.0019</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Rescue Medication Use</title>
        <description>average albuterol rescue use per week, measured by electronic diary</description>
        <time_frame>last 46 weeks of 48 week treatment period</time_frame>
        <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Rescue Medication Use</title>
          <description>average albuterol rescue use per week, measured by electronic diary</description>
          <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
          <units>inhalations per week</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="2.3" upper_limit="3.3"/>
                    <measurement group_id="O2" value="3" lower_limit="2.4" upper_limit="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.69</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.9</ci_lower_limit>
            <ci_upper_limit>0.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Care Utilization</title>
        <description>frequency of unscheduled physician visits, emergency department visits or hospitalizations for asthma</description>
        <time_frame>last 46 weeks of 48 week treatment period</time_frame>
        <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
          </group>
        </group_list>
        <measure>
          <title>Health Care Utilization</title>
          <description>frequency of unscheduled physician visits, emergency department visits or hospitalizations for asthma</description>
          <population>Two participants in the ibuprofen arm dropped out of the study during the first two weeks of the study and were not included in the analysis per the pre-specified analysis plan.</population>
          <units>unscheduled health visits per 46 weeks</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".75" lower_limit=".6" upper_limit=".95"/>
                    <measurement group_id="O2" value=".76" lower_limit=".6" upper_limit=".97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.94</p_value>
            <method>log-linear model</method>
            <method_desc>log-linear model in which the number of exacerbations was assumed to follow a negative binomial distribution</method_desc>
            <param_type>relative rate</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>1.37</ci_upper_limit>
            <estimate_desc>relative rate with acetaminophen in the numerator and ibuprofen in the denominator</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen</title>
          <description>acetaminophen given as needed for pain or fever
Acetaminophen: 15 mg/kg every 6 hours as needed</description>
        </group>
        <group group_id="E2">
          <title>Ibuprofen</title>
          <description>ibuprofen given as needed for pain or fever
Ibuprofen: 9.4 mg/kg every 6 hours as needed</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Simple laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>asthma exacerbation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>tonsilitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="135" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="124" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Otitis media NOS</sub_title>
                <counts group_id="E1" events="56" subjects_affected="37" subjects_at_risk="150"/>
                <counts group_id="E2" events="60" subjects_affected="34" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="150"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="150"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="230" subjects_affected="92" subjects_at_risk="150"/>
                <counts group_id="E2" events="176" subjects_affected="75" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="22" subjects_affected="13" subjects_at_risk="150"/>
                <counts group_id="E2" events="33" subjects_affected="15" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Strep sore throat</sub_title>
                <counts group_id="E1" events="19" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute uri</sub_title>
                <counts group_id="E1" events="279" subjects_affected="94" subjects_at_risk="150"/>
                <counts group_id="E2" events="198" subjects_affected="73" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Allergic rhinitis</sub_title>
                <counts group_id="E1" events="76" subjects_affected="39" subjects_at_risk="150"/>
                <counts group_id="E2" events="57" subjects_affected="38" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="17" subjects_affected="10" subjects_at_risk="150"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="55" subjects_affected="32" subjects_at_risk="150"/>
                <counts group_id="E2" events="61" subjects_affected="30" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Mauger, PhD</name_or_title>
      <organization>Penn State University Dept of Public Health Sciences</organization>
      <phone>717.573.0336</phone>
      <email>dmauger@psu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

